Fatigue News and Research

RSS

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

The placebo effect is the well-known phenomenon of a person's physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit – a sugar pill, or a syringe full of saline, for example.

18 Jan 2022

Feeling threatened and being informed predicted more social distancing, study shows

If the COVID-19 virus mutates beyond Omicron, getting people to practice social distancing will require more than threats about long-term health issues or death.

18 Jan 2022

Effects of post-acute COVID-19 on physical and mental health in women

The current study attempts to measure the difference in mood, functional status, and leisure-time physical activity in women with a history of COVID-19.

17 Jan 2022

Sniffer dogs detect long COVID after 1.5 years

Researchers used sniffer dogs to test the presence of SARS-CoV-2 infection in axillary sweat samples of long COVID-19 patients.

17 Jan 2022

New data fusion method classifies skin lesions more precisely than prior algorithms

Dermatologists typically classify skin lesions based on multiple data sources. Algorithms that fuse the information together can support this classification. An international research team has now developed an algorithm that classifies skin lesions more accurately than previous algorithms by using an improved data fusion process.

17 Jan 2022

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Researchers determine whether sequences within SARS-CoV-2 could lead to an immune response to autoantigens associated with autoimmune myocarditis.

13 Jan 2022

Prevalence of persistent Long COVID symptoms after SARS-CoV-2 infection

In a new study, researchers aimed to analyze the prevalence and severity of persistent symptoms in the first year of COVID-19 infection as compared to non-infected individuals.

13 Jan 2022

Low incidence strategy for control of COVID-19

In a study published in The Lancet Regional Health – Europe, researchers from the Institute for Advanced Studies in Vienna argued for the benefits of a low incidence strategy to control the disease.

13 Jan 2022

New type of blood test can be used to detect cancers as well as metastatic disease

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.

12 Jan 2022

Real-world effectiveness of three COVID-19 vaccines

Researchers from IQVIA Real-World Solutions have investigated how effective these vaccines are against severe disease.

11 Jan 2022

A study on COVID vaccinated vs. unvaccinated that required hospitalization

Researchers compared the characteristics of fully vaccinated and boosted and unvaccinated patients requiring hospitalization for COVID-19.

10 Jan 2022

Research may lead to new treatment options for Crohn's disease patients

Results of a new study by researchers at Case Western Reserve University represent a step toward improving our understanding of Crohn's disease and the factors that cause its intestinal inflammation.

10 Jan 2022

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

The National Comprehensive Cancer Network today announced the publication of new NCCN Guidelines for Patients: Graft-Versus-Host Disease (GVHD).

10 Jan 2022

Association of vaccination status with Long COVID symptoms

Scientists examined whether vaccination was associated with reporting long-term symptoms post-SARS-CoV-2 infection.

10 Jan 2022

Comparison of COVID-19 and influenza-associated complications

Researchers compare the number, types, and risk for complications among COVID-19 and influenza patients using claims data.

9 Jan 2022

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Severe and persistent disability often undermines the life-saving benefits of cancer treatment. Pain and fatigue - together with sensory, motor, and cognitive disorders - are chief among the constellation of side effects that occur with the platinum-based agents used widely in chemotherapy treatments worldwide.

9 Jan 2022

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced the first participant has been dosed in the Phase 1 study of mRNA-1189, the Company's Epstein-Barr Virus vaccine candidate.

7 Jan 2022

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

In a recently published article in the journal Nano-Micro Letters, scientists have provided an in-depth review on the application and benefits of nanotechnology in the development of coronavirus disease 2019 (COVID-19) vaccines.

7 Jan 2022

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

New research recently unveiled the utility of melatonin and melatonin-derived medicines in reducing brain entry of severe acute respiratory syndrome coronavirus 2 and subsequently preventing long-term neurological consequences of coronavirus disease 2019.

6 Jan 2022

Public attitudes to the COVID-19 pandemic during the emergence of the Omicron variant

Researchers from Swansea University have been investigating public attitudes to the pandemic.

5 Jan 2022

Fatigue News and Research

"Nocebo effect" accounts for 76% of all adverse events in the COVID-19 vaccine trial group

Feeling threatened and being informed predicted more social distancing, study shows

Effects of post-acute COVID-19 on physical and mental health in women

Sniffer dogs detect long COVID after 1.5 years

New data fusion method classifies skin lesions more precisely than prior algorithms

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Prevalence of persistent Long COVID symptoms after SARS-CoV-2 infection

Low incidence strategy for control of COVID-19

New type of blood test can be used to detect cancers as well as metastatic disease

Real-world effectiveness of three COVID-19 vaccines

A study on COVID vaccinated vs. unvaccinated that required hospitalization

Research may lead to new treatment options for Crohn's disease patients

NCCN publishes new guidelines for managing patients with Graft-Versus-Host Disease

Association of vaccination status with Long COVID symptoms

Comparison of COVID-19 and influenza-associated complications

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

Public attitudes to the COVID-19 pandemic during the emergence of the Omicron variant

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News